Associations of anticoagulant use with outcome in newly diagnosed glioblastoma

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

Olivier Chinot, Wolfgang Wick, Warren Mason et al. · New England Journal of Medicine · 2014 · 2.4K citations · Full text

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia et al. · The Lancet Oncology · 2014 · 1K citations

Neuro-oncology, Glioma, Medicine +9

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Christine Wild‐Bode, Michael Weller, Andreas Rimner et al. · PubMed · 2001 · 461 citations

High-grade Gliomas, Radiation Biology, Cancer Biology +18

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

James Perry, J.A. Julian, Normand Laperrière et al. · Journal of Thrombosis and Haemostasis · 2010 · 245 citations

Neuro-oncology, Thrombosis, Glioma +10

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Burt Nabors, Karen Fink, Tom Mikkelsen et al. · Neuro-Oncology · 2015 · 231 citations · Full text